Literature DB >> 19515282

New insights into the organization of the basal ganglia.

James B Koprich1, Tom H Johnston, Philippe Huot, Susan H Fox, Jonathan M Brotchie.   

Abstract

Understanding the functional organization of the basal ganglia requires a broad array of complementary theoretical models. Although the basal ganglia operate as part of a system of parallel cortico-basal ganglia-thalamocortical loops, there is clearly integration between the loops and there are probably more of these loops than previously conceived. Moreover, modulation by external inputs, particularly from the brainstem (eg, pedunculopontine nucleus, raphe nucleus, and locus coeruleus) adds to the complexity of the system. We now appreciate that the organization of the basal ganglia is not static and shows significant plasticity that allows the ganglia to function in learning processes and in response to age or disease, either as components of the pathophysiology or as compensatory mechanisms to reduce the functional impact of disease.

Mesh:

Year:  2009        PMID: 19515282     DOI: 10.1007/s11910-009-0045-2

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  74 in total

1.  Nigral and pallidal inputs to functionally segregated thalamostriatal neurons in the centromedian/parafascicular intralaminar nuclear complex in monkey.

Authors:  Mamadou Sidibé; Jean-François Paré; Yoland Smith
Journal:  J Comp Neurol       Date:  2002-06-03       Impact factor: 3.215

Review 2.  Modulation of the basal ganglia by metabotropic glutamate receptors: potential for novel therapeutics.

Authors:  Michael J Marino; P Jeffrey Conn; Jeffrey P Conn
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2002-06

3.  Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.

Authors:  Alessandro Stefani; Andres M Lozano; Antonella Peppe; Paolo Stanzione; Salvatore Galati; Domenicantonio Tropepi; Mariangela Pierantozzi; Livia Brusa; Eugenio Scarnati; Paolo Mazzone
Journal:  Brain       Date:  2007-01-24       Impact factor: 13.501

4.  Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of Parkinson's disease.

Authors:  Jordi Gomez-Ramirez; Tom H Johnston; Naomi P Visanji; Susan H Fox; Jonathan M Brotchie
Journal:  Mov Disord       Date:  2006-06       Impact factor: 10.338

5.  Medication-induced hallucination and cerebral blood flow in Parkinson's disease.

Authors:  K Okada; N Suyama; H Oguro; S Yamaguchi; S Kobayashi
Journal:  J Neurol       Date:  1999-05       Impact factor: 4.849

6.  Hallucinations and sleep disorders in PD: six-year prospective longitudinal study.

Authors:  Christopher G Goetz; Joanne Wuu; Linda M Curgian; Sue Leurgans
Journal:  Neurology       Date:  2005-01-11       Impact factor: 9.910

7.  GABAergic interneurons in human subthalamic nucleus.

Authors:  Julie-Christine Lévesque; André Parent
Journal:  Mov Disord       Date:  2005-05       Impact factor: 10.338

Review 8.  Adjuncts to dopamine replacement: a pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease.

Authors:  J M Brotchie
Journal:  Mov Disord       Date:  1998-11       Impact factor: 10.338

9.  Long collateral branches of substantia nigra pars reticulata axons to thalamus, superior colliculus and reticular formation in monkey and cat. Multiple retrograde neuronal labeling with fluorescent dyes.

Authors:  R M Beckstead
Journal:  Neuroscience       Date:  1983-11       Impact factor: 3.590

10.  High-frequency stimulation of the subthalamic nucleus suppresses oscillatory beta activity in patients with Parkinson's disease in parallel with improvement in motor performance.

Authors:  Andrea A Kühn; Florian Kempf; Christof Brücke; Louise Gaynor Doyle; Irene Martinez-Torres; Alek Pogosyan; Thomas Trottenberg; Andreas Kupsch; Gerd-Helge Schneider; Marwan I Hariz; Wim Vandenberghe; Bart Nuttin; Peter Brown
Journal:  J Neurosci       Date:  2008-06-11       Impact factor: 6.167

View more
  1 in total

1.  Deep brain stimulation of the subthalamic nucleus, but not dopaminergic medication, improves proactive inhibitory control of movement initiation in Parkinson's disease.

Authors:  Emilie Favre; Bénédicte Ballanger; Stéphane Thobois; Emmanuel Broussolle; Philippe Boulinguez
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.